Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Agilon Health (AGL) EPS (Weighted Average and Diluted) (2020 - 2025)

Agilon Health's EPS (Weighted Average and Diluted) history spans 6 years, with the latest figure at -$0.46 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 76.92% year-over-year to -$0.46; the TTM value through Dec 2025 reached -$0.98, down 60.66%, while the annual FY2025 figure was -$0.98, 60.66% down from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.46 in Q4 2025 per AGL's latest filing, down from -$0.27 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.02 in Q1 2023 to a low of -$0.46 in Q4 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.12, with a median of -$0.06 recorded in 2023.
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 2387.49% in 2022, then skyrocketed 1876.99% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.06 in 2021, then crashed by 76.38% to -$0.1 in 2022, then plummeted by 310.0% to -$0.41 in 2023, then skyrocketed by 36.59% to -$0.26 in 2024, then crashed by 76.92% to -$0.46 in 2025.
  • Per Business Quant, the three most recent readings for AGL's EPS (Weighted Average and Diluted) are -$0.46 (Q4 2025), -$0.27 (Q3 2025), and -$0.25 (Q2 2025).